Related references
Note: Only part of the references are listed.Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
Christoph F. R. Hatz et al.
VACCINE (2015)
An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children
Richard I. Walker
VACCINE (2015)
Glycoconjugate vaccines: an update
Mairi Vella et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation
Michael M. Kaempf et al.
MICROBIAL CELL FACTORIES (2015)
Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
Sofie Livio et al.
CLINICAL INFECTIOUS DISEASES (2014)
Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
Michael Wacker et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Development of Vi conjugate - a new generation of typhoid vaccine
Shousun Chen Szu
EXPERT REVIEW OF VACCINES (2013)
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component
Michael Wetter et al.
GLYCOCONJUGATE JOURNAL (2013)
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
Karen L. Kotloff et al.
LANCET (2013)
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
Li Liu et al.
LANCET (2012)
Automatic Structure Determination of Regular Polysaccharides Based Solely on NMR Spectroscopy
Magnus Lundborg et al.
BIOMACROMOLECULES (2011)
Production of glycoprotein vaccines in Escherichia coli
Julian Ihssen et al.
MICROBIAL CELL FACTORIES (2010)
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children
Justen H. Passwell et al.
VACCINE (2010)
Separation and quantification of component monosaccharides of the tea polysaccharides from Gynostemma pentaphyllum by HPLC with indirect UV detection
You Lv et al.
FOOD CHEMISTRY (2009)
Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan
Afia Zafar et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection
Armelle Phalipon et al.
JOURNAL OF IMMUNOLOGY (2009)
Rapid and sensitive anthrone-sulfuric acid assay in microplate format to quantify carbohydrate in biopharmaceutical products:: Method development and validation
Alberto Leyva et al.
BIOLOGICALS (2008)
Effect of the nonreducing end of Shigella dysenteriae type 10-specific oligosaccharides on their immunogenicity as conjugates in mice
Vince Pozsgay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003
John T. Brooks et al.
CLINICAL INFECTIOUS DISEASES (2006)
A multicentre study of Shigella diarrhoea in six Asian countries: Disease burden, clinical manifestations, and microbiology
Lorenz von Seidlein et al.
PLOS MEDICINE (2006)
Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries
RI Walker
VACCINE (2005)
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
MF Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000
SD Putnam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children
JH Passwell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis
MI Fernandez et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2003)
N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli
M Wacker et al.
SCIENCE (2002)
Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture
C Jones et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel
JH Passwell et al.
INFECTION AND IMMUNITY (2001)
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
KA Datsenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Production of IFN-γ and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain
T Samandari et al.
JOURNAL OF IMMUNOLOGY (2000)
NMR spectroscopy, molecular dynamics, and conformation of a synthetic octasaccharide fragment of the O-specific polysaccharide of Shigella dysenteriae type 1
B Coxon et al.
CARBOHYDRATE RESEARCH (2000)
Share Paper
